drugset / Trial / NCT05820880

Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

NCT05820880

Phase 3 Completed 532 enrolled Servier
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of a fixed-dose combination of perindopril 5 mg /indapamide 1.25 mg / amlodipine 5 mg compared to the free combination of the same components (perindopril 4 mg / indapamide 1.25 mg in a single pill and amlodipine 5 mg pill given separately at the same time) in chinese patients with uncontrolled essential hypertension.

Timeline

Start
2019-05-06
Primary completion
2022-02-23
Completion
2022-02-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg
Subject Amlodipine Other / unclassified 10 mg
Subject Indapamide Small molecule 1.25 mg
Subject Indapamide Small molecule 2.5 mg
Subject Perindopril Small molecule 4 mg
Subject Perindopril Small molecule 5 mg
Subject Perindopril Small molecule 10 mg